With 3 days of jam-packed content and 35+ world class speakers pioneering the next wave of ALS therapies, the 2^nd ALS Drug Development Summit is biopharma’s can’t-miss meeting for the acceleration of ALS drug development pipelines.

Join 100+ of your biopharma peers to uncover cutting-edge ALS biomarkers, including neurofilament light chain, to incorporate into clinical trials, improve in vitro and in vivo ALS preclinical models to improve translation of safe and efficacious therapies and optimize clinical trial design and endpoints to maximise data collection in an evolving standard of care.

Browse the full Event Guide to discover:

• 37+ expert ALS speakers across 3 jam-packed conference days, spanning all stages of the drug development pipeline

• Doubled pre-conference workshop content, with 4 deep-dive workshops facilitating interactive discussions on novel ALS target discovery, preclinical strategy, wearable technology, and clinical trial design

• Opening conference discussion on recent and upcoming FDA approvals to learn key takeaways from interacting with regulatory bodies

• Hear directly from patient advocates and individuals living with ALS to understand their perspective on ALS drug development and engagement in clinical research

• Dedicated networking, roundtable discussion and poster sessions to share your insights with other ALS leaders in the room

To know more visit: https://ter.li/21k4zy